Strides Pharma to acquire arms of Endo in U.S for $24 mn
The Hindu
With this acquisition, Strides would have doubled its US portfolio with the potential to launch 5-6 new products each quarter going forward.
City-based Strides Pharma Science Limited (Strides) on Friday said its wholly-owned subsidiaries have entered into definitive agreements with subsidiaries of Endo International plc (Endo) to acquire its manufacturing facility at Chestnut Ridge, New York, for $ 24 million. The new portfolio has 20 commercial products and a basket of dormant ANDAs (abbreviated new drug applications) that are expected to fast track Strides’ new product launch strategy for US markets, as per the communique.
RBI Deputy Governor T. Rabi Sankar dismisses stablecoins in India, citing lack of fundamental value and risks to monetary policy.
Union Cabinet approves coal export policy, allowing 50% of auctioned coal for any industrial use and export.
Union Cabinet approves coal export policy, allowing 50% of auctioned coal for any industrial use and export.
Cabinet approves a bill to increase FDI in the insurance sector to 100%, enhancing growth and business ease.
Sensex surges nearly 450 points driven by metal shares and positive global trends, with Nifty also rising above 26,000.
Sensex rises nearly 450 points amid metal shares buying and positive global trends, with Tata Steel and Maruti among top gainers.
India and New Zealand are working to expedite Free Trade Agreement negotiations to enhance trade and investment benefits.
The rupee falls 9 paise to a record low of 90.41 against the dollar amid trade deal uncertainties and foreign fund outflows.
Mercedes-Benz India will increase vehicle prices by up to 2% in January to counter rising costs and currency pressures.
CCI is investigating if IndiGo violated competition norms amid significant flight disruptions and concerns over its dominant market position.
The Coal Controller Organisation is appointed to regulate and register proposed coal exchanges, enhancing market competition and oversight.
The rupee hits a record low amid U.S. trade stalemate and portfolio outflows, prompting potential RBI intervention.
November 2025 sees robust growth in India's auto industry, with record sales in passenger vehicles, two-wheelers, and three-wheelers.